Acute renal failure induced by renal ischemia or drugs continues to be a relevant clinical problem. Li et al. have demonstrated that proximal tubule-restricted peroxisome proliferator–activated receptor-α (PPARα) expression in transgenic mice reduced cisplatin- and ischemia/reperfusion-induced acute renal injury. Their article suggests a role for the maintenance of free fatty acid oxidation in the proximal tubule as a mechanism of nephroprotection, as well as a potential clinical utility of PPARα activators in the prevention of acute renal failure
This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism.Peroxis...
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Per...
Interstitial fibrosis plays a major role in the progression of renal diseases. Peroxisome proliferat...
Acute renal failure induced by renal ischemia or drugs continues to be a relevant clinical problem. ...
Fibrate peroxisome proliferator-activated receptor (PPAR)-α ligands are mainly used as hypolipidemic...
Doxorubicin (DOX) is an anthracycline antibiotic utilized in antitumor therapy; however, its clinica...
Our previous studies suggest that peroxisome proliferator–activated receptor-α (PPARα) plays a criti...
Peroxisome proliferator-activated receptor (PPAR)-α, a member of a large nuclear receptor superfamil...
The Goldblatt’s 2 kidney 1 clip (2K1C) rat animal model of renovascular hypertension is characterize...
The Goldblatt’s 2 kidney 1 clip (2K1C) rat animal model of renovascular hypertension is characterize...
Chronic kidney disease (CKD) has become a global healthcare issue. CKD can progress to irreversible ...
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Per...
Chronic kidney disease (CKD) has become a global healthcare issue. CKD can progress to irreversible ...
A growing body of evidence suggests that chronic kidney disease is a significant risk for cardiovasc...
Summary: Diminished insulin sensitivity is a characteristic feature of various pathological conditio...
This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism.Peroxis...
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Per...
Interstitial fibrosis plays a major role in the progression of renal diseases. Peroxisome proliferat...
Acute renal failure induced by renal ischemia or drugs continues to be a relevant clinical problem. ...
Fibrate peroxisome proliferator-activated receptor (PPAR)-α ligands are mainly used as hypolipidemic...
Doxorubicin (DOX) is an anthracycline antibiotic utilized in antitumor therapy; however, its clinica...
Our previous studies suggest that peroxisome proliferator–activated receptor-α (PPARα) plays a criti...
Peroxisome proliferator-activated receptor (PPAR)-α, a member of a large nuclear receptor superfamil...
The Goldblatt’s 2 kidney 1 clip (2K1C) rat animal model of renovascular hypertension is characterize...
The Goldblatt’s 2 kidney 1 clip (2K1C) rat animal model of renovascular hypertension is characterize...
Chronic kidney disease (CKD) has become a global healthcare issue. CKD can progress to irreversible ...
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Per...
Chronic kidney disease (CKD) has become a global healthcare issue. CKD can progress to irreversible ...
A growing body of evidence suggests that chronic kidney disease is a significant risk for cardiovasc...
Summary: Diminished insulin sensitivity is a characteristic feature of various pathological conditio...
This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism.Peroxis...
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Per...
Interstitial fibrosis plays a major role in the progression of renal diseases. Peroxisome proliferat...